This information does not take the place of talking with your healthcare provider, and it does not include all of the important information about ADYNOVATE
And Novo Nordisk's supply capacity, because if another shortage occurs, the compounding pathway reopens regardless of legal battles
Transdermal-specific considerations for patches would include: Local skin reactions (erythema, itching, irritation at application site) Contact dermatitis from adhesive components or penetration enhancers Skin integrity concerns requiring regular site rotation Patient safety advice for anyone using GLP-1 therapy includes: Report persistent severe abdominal pain (potential pancreatitis) Monitor for signs of gallbladder problems (right upper quadrant pain, particularly after meals) Maintain adequate hydration, especially if experiencing vomiting or diarrhoea Contact your GP if side effects are severe, persistent, or concerning Report suspected side effects via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk) Regarding pregnancy and breastfeeding, advice varies by product
Characterization of microbiota in bronchiectasis patients with different disease severities
Mild GI symptoms, such as nausea or bloating, may still arise during the adjustment period and often ease over time
doi: 10.3390/diagnostics12071767